The invention relates to a method of chromatography wherein a gaseous, liquid or supercritical fluid mobile phase, which contains substances to be separated, flows through a porous packing which comprises a plurality of capillary channels which extend in the direction of flow of said mobile phase, said packing being manufactured by a method wherein: a bundle of elementary fibres is assembled, said fibres comprising a core made of a solid, liquid or gaseous material, and a shell made of a drawable material, said bundle is drawn in order to reduce the diameter of said fibres, a porous matrix is formed around the core of the drawn fibres, the formation of said porous matrix comprising a transformation of the shell material, where said porous matrix comprises at least one population of connected pores interconnecting the channels, where the thickness of the porous matrix between two adjacent channels is less than the diameter of the channels, preferably less than half the diameter of the channels, where necessary the core material is removed so as to leave free channels in the porous matrix.

The invention relates to a method of chromatography wherein a gaseous, liquid or supercritical fluid mobile phase, which contains substances to be separated, flows through a porous packing which comprises a plurality of capillary channels which extend in the direction of flow of said mobile phase, said packing being manufactured by a method wherein: a bundle of elementary fibres is assembled, said fibres comprising a core made of a solid, liquid or gaseous material, and a shell made of a drawable material, said bundle is drawn in order to reduce the diameter of said fibres, a porous matrix is formed around the core of the drawn fibres, the formation of said porous matrix comprising a transformation of the shell material, where said porous matrix comprises at least one population of connected pores interconnecting the channels, where the thickness of the porous matrix between two adjacent channels is less than the diameter of the channels, preferably less than half the diameter of the channels, where necessary the core material is removed so as to leave free channels in the porous matrix.

The invention relates to a method for preparation of a sample (10) of a formulation (11) for subsequent endotoxin determination, the formulation (11) suspected of comprising an endotoxin, the formulation (11) preferentially being a pharmaceutical formulation. The method comprises the following steps: application of the sample (10) to an endotoxin-free centrifugation column (2) containing a size exclusion chromatography matrix (5) that has been equilibrated with a suitable equilibration buffer (6) and elution of a flow through (15) of the sample by centrifugation, which flow through (15) can then be used for endotoxin determination. The equilibration buffer (6) is selected according to a subsequently used method of endotoxin determination, the equilibration buffer (6) only containing components not interfering with subsequently used method of endotoxin determination. Furthermore, the invention relates to a kit (20) for preparation of a sample (10).

A method for enhancing a sorbent membrane for carbon dioxide capture is disclosed. The method includes applying a layer of a hydrophobic material to at least one surface of the sorbent membrane. The hydrophobic material may be one of a polysioxane, a silicone compound, and a fluoroacrylic copolymer. The sorbent membrane may be an anionic exchange membrane, and may have a quaternary ammonium functional group. The layer of hydrophobic material reduces the amount of water used in the carbon dioxide capture process, and relaxes the water quality constraints.

A method for enhancing a sorbent membrane for carbon dioxide capture is disclosed. The method includes applying a layer of a hydrophobic material to at least one surface of the sorbent membrane. The hydrophobic material may be one of a polysioxane, a silicone compound, and a fluoroacrylic copolymer. The sorbent membrane may be an anionic exchange membrane, and may have a quaternary ammonium functional group. The layer of hydrophobic material reduces the amount of water used in the carbon dioxide capture process, and relaxes the water quality constraints.

Embodiments of a method of purifying a lysophosphatidylcholine (e.g., LPC-DHA and/or LPC-EPA) from a composition containing the lysophosphatidylcholine and at least one impurity, e.g., from phospholipids, free fatty acids, triacylglycerols (TAGs), diacylglycerols (DAGs), monoacylglycerols (MAGs), glycerol, sterols, tocopherols, vitamin A, flavonoids, and minerals can use a continuous simulated moving bed process, a batch column chromatography method, or a single column to provide a purified composition of the lysophosphatidylcholine. The purified lysophosphatidylcholine (e.g., LPC-DHA and/or LPC-EPA) products can be used in various pharmaceutical and nutraceutical applications, e.g., for treating and/or preventing a neurological disease or disorder.

The subject invention pertains to proteins are purified by a mixed-mode chromatography system formed by attaching a ligand with cation exchange and hydrophobic 1,3-dioxoisoindolin-2-yl group functionalities to a large-pore support matrix, the only linkage between the ligand and the support matrix being a chain having a backbone of one, two, three, four, or five atoms between the hydrophobic group and the support matrix.

The subject invention pertains to proteins are purified by a mixed-mode chromatography system formed by attaching a ligand with cation exchange and hydrophobic 1,3-dioxoisoindolin-2-yl group functionalities to a large-pore support matrix, the only linkage between the ligand and the support matrix being a chain having a backbone of one, two, three, four, or five atoms between the hydrophobic group and the support matrix.

The invention relates to a method of isolating an immunoglobulin, comprising the steps of: a) providing a separation matrix comprising multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support: b) contacting a liquid sample comprising an immunoglobulin with the separation matrix; c) washing said separation matrix with a washing liquid; d) eluting the immunoglobulin from the separation matrix with an elution liquid, and e) cleaning the separation matrix with a cleaning liquid, wherein the alkali-stabilized Protein A domains comprise mutants of a parental Fc-binding domain of Staphylococcus Protein A (SpA).

According to an example aspect of the present invention, there is provided a method of detecting carbon dioxide in a gaseous sample, the method comprising: flowing the gaseous sample through an anion exchange resin that is capable of selectively adsorbing CO.sub.2 present in the gaseous sample; releasing the adsorbed CO.sub.2 from the resin by heating the resin to a temperature in the range 80 to 250° C. to obtain a concentrated gaseous sample; determining the amount of an isotopic form of CO.sub.2 in the concentrated gaseous sample by infrared absorption spectroscopy.